4//SEC Filing
Kelley Shannon T 4
Accession 0001628280-26-002742
CIK 0001157601other
Filed
Jan 19, 7:00 PM ET
Accepted
Jan 20, 5:58 PM ET
Size
6.6 KB
Accession
0001628280-26-002742
Insider Transaction Report
Form 4
Kelley Shannon T
General Counsel
Transactions
- Sale
Common Stock
[F1]2026-01-20$490.77/sh−263$129,073→ 8,910 total - Sale
Common Stock
[F2]2026-01-20$501.40/sh−429$215,101→ 8,481 total
Footnotes (2)
- [F1]This sale represents the number of shares sold by the Issuer on behalf of the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. This sale was automatic and not at the discretion of the Reporting Person.
- [F2]This sale was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 7, 2024.
Signature
/s/ Mardi Dier, as Attorney-in-Fact|2026-01-20
Documents
Issuer
MADRIGAL PHARMACEUTICALS, INC.
CIK 0001157601
Entity typeother
Related Parties
1- filerCIK 0002034056
Filing Metadata
- Form type
- 4
- Filed
- Jan 19, 7:00 PM ET
- Accepted
- Jan 20, 5:58 PM ET
- Size
- 6.6 KB